Error: Could not add to watchlist. X

BB Adamant Global Medtech und

+ Watchlist
ADAGMED:SW
1,443.27
CHF
26.94
1.83%
As of 11:50 AM EST on 2/9/2016.
Fund Type
Open-End Fund
52Wk Range
1,470.21 - 1,841.45
1 Yr Return
-6.15%
YTD Return
-17.20%
Previous Close
1,470.21
52Wk Range
1,470.21 - 1,841.45
1 Yr Return
-4.28%
YTD Return
-17.20%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 02/09/2016)
1,443.27
Total Assets (m CHF) (on 02/09/2016)
78.430
Inception Date
03/03/2008
Last Dividend (on 12/03/2015)
-
Dividend Indicated Gross Yield
-
Fund Managers
JOHN MANIERI
Front Load Fee
2.50%
Back Load Fee
1.00%
Redemption Fee
1.00%
12b-1 Fee
-
Current Mgmt Fee
1.81%
Expense Ratio
1.84%
Top Fund Holdings
Name Position Value % of Fund
UnitedHealth Group Inc 110.00 k 12.77 m 12.61
Medtronic PLC 100.00 k 7.29 m 7.20
Abbott Laboratories 163.00 k 7.20 m 7.11
Express Scripts Holding Co 80.00 k 6.81 m 6.73
Cigna Corp 48.00 k 6.34 m 6.26
Aetna Inc 53.00 k 6.00 m 5.92
Humana Inc 30.00 k 5.28 m 5.22
McKesson Corp 26.00 k 4.58 m 4.53
Anthem Inc 30.00 k 4.12 m 4.06
Stryker Corp 35.00 k 3.30 m 3.26
Profile
BB Adamant Global Medtech und Services is an open-ended investment company incorporated in Switzerland. The Fund's aim is to generate long-term capital growth through active management by investing in companies within the medicinal sector. The Fund's portfolio will be concentarted to around 30 to 50 stocks which fully meet Adamant's strict selection criteria.
ADDRESS
Balfidor Fondsleitung AG
Peter-Merian Strasse 47
CH 4002 Basel
Switzerland
PHONE
+41 800 850 050